MedTrace Logo

EpiFaith CV for Central Venous Catheterization

NCT06043895 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-09-22

No results posted yet for this study

Summary

EpiFaith CV provides automatic aspiration and detection of arterial pressure as an alternative to manometry in central venous catheterization. The aim of the study is to evaluate if it may reduce operation time compared with conventional syringe.

Conditions

  • Catheterization, Central Venous
  • Equipment Design
  • Patient Safety
  • Anesthesiology Devices Associated With Misadventures, Diagnostic and Monitoring Devices
  • Perioperative Care

Interventions

DEVICE

EpiFaith CV

The conducting physician will localize the central vein using EpiFaith CV and assess if there is arterial puncture.

DEVICE

Conventional

The conducting physician will localize the central vein using Raulerson syringe and assess if there is arterial puncture.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Man-Ling Wang, MD, PhD · Department of Anesthesiology, National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06043895 on ClinicalTrials.gov